TITLE

High-Normal Platelet Factor 4-Heparin Antibodies and Mortality in Hemodialysis Patients

AUTHOR(S)
Ringenberg, Roy
PUB. DATE
February 2006
SOURCE
Mayo Clinic Proceedings;Feb2006, Vol. 81 Issue 2, p263
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to an article on the association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients, published in the August 2005 issue.
ACCESSION #
19787543

 

Related Articles

  • Heparin recall and India. Sharma, V.; Sharma, A.; Aggarwal, S. // Journal of Postgraduate Medicine;Oct-Dec2008, Vol. 54 Issue 4, p335 

    A letter to the editor is presented in response to the article "Story of heparin recall: What can India do?" in the previous issue.

  • Low Molecular Weight Heparins. Von Tempelhoff, G.-F.; Wolf, H.; Herrie, B.; Hojnacki, B.; Heilmann, L. // Clinical & Applied Thrombosis/Hemostasis;Fall1996, Vol. 2 Issue 4, p292 

    Presents a letter to the editor in response to the article "Use of low molecular weight heparin in malignancy-related thromboembolic disorders: a clinical review," by Dr. Goodwin in a 1996 issue.

  • Enoxaparin in Elective Percutaneous Coronary Intervention. Bhala, Neeraj // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2788 

    A letter to the editor is presented in response to the article "Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention," by Gilles Montalescot and colleagues in the September 7, 2006 issue.

  • Enoxaparin in Elective Percutaneous Coronary Intervention. Hamon, Martial; Riddell, John W. // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2788 

    A letter to the editor is presented in response to the article "Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention," by Gilles Montalescot and colleagues in the September 7, 2006 issue.

  • Enoxaparin in Elective Percutaneous Coronary Intervention. Karthikeyan, Ganesan // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2788 

    A letter to the editor is presented in response to the article "Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention," by Gilles Montalescot and colleagues in the September 7, 2006 issue.

  • Enoxaparin in Elective Percutaneous Coronary Intervention. Pasceri, Vincenzo // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2788 

    A letter to the editor is presented in response to the article "Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention," by Gilles Montalescot and colleagues in the September 7, 2006 issue.

  • Enoxaparin in Elective Percutaneous Coronary Intervention. Schuler, Jochen; Altenberger, Johann; Heigert, Mathias // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2788 

    A letter to the editor is presented in response to the article "Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention," by Gilles Montalescot and colleagues in the September 7, 2006 issue.

  • Enoxaparin in Elective Percutaneous Coronary Intervention. Montalescot, Gilles; White, Harvey D.; Steinhubl, Steven R. // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2788 

    A response by Gilles Montalescot, Harvey D. White and Steven R. Steinhubl to several letters to the editor about their article "Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention," in the September 7, 2006 issue is presented.

  • Contaminated Heparin. Greinacher, Andreas; Warkentin, Theodore E. // New England Journal of Medicine;9/18/2008, Vol. 359 Issue 12, p1291 

    A letter to the editor is presented in response to thee article "Contaminated Heparin Associated With Adverse Clinical Events and Activation of the Contact System" by T. K. Kishimoto, K. Viswanathan and T. Ganguly in the June 5, 2008 issue.

  • Contaminated Heparin. Kakkar, Ajay K.; Bonnefoi, Marc // New England Journal of Medicine;9/18/2008, Vol. 359 Issue 12, p1291 

    A letter to the editor is presented in response to the article "Contaminated Heparin Associated With Clinical Events and Activation of the Contact System" by T. K. Kishimoto, K. Viswanathan and T. Ganguly in the June 5, 2008 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics